Literature DB >> 1359702

Pituitary lactotrophs and somatotrophs in pregnancy: a correlative in situ hybridization and immunocytochemical study.

L Stefaneanu1, K Kovacs, R V Lloyd, B W Scheithauer, W F Young, T Sano, L Jin.   

Abstract

Lactotroph hyperplasia is a prominent finding in the adenohypophyses of pregnant women. In order to elucidate the morphogenesis of this change, pituitaries from 16 women in various phases of pregnancy were collected at autopsy and studied by histology, immunocytochemistry and in situ hybridization. The results showed that the increase in the amount of prolactin (PRL) mRNA paralleled the progressive lactotroph hyperplasia. The presence of mitoses in PRL-immunoreactive cells provided evidence that proliferation of preexisting lactotrophs contribute to lactotroph accumulation. Growth hormone (GH) immunoreactive cells showed a marked reduction in GH mRNA indicating that GH synthesis was inhibited. In many GH-immunoreactive cells, PRL mRNA became apparent. These findings demonstrate that GH is stored following discontinuation of GH synthesis. It appears that, when PRL is secreted in excess during pregnancy, somatotrophs are recruited to produce PRL. These somatotrophs begin to express PRL mRNA, transform to bihormonal mammosomatotrophs and possibly later to lactotrophs, contributing to PRL production. Mature somatotrophs may be regarded as reserve cells in the adenohypophysis, having the potential to switch hormone synthesis and to convert to mammosomatotrophs and possibly lactotrophs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359702     DOI: 10.1007/bf02899695

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  16 in total

Review 1.  Aspects of anterior pituitary growth, with special reference to corticotrophs.

Authors:  A M McNicol; E Carbajo-Perez
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Vascularity in Nontumorous Human Pituitaries and Incidental Microadenomas: A Morphometric Study.

Authors:  Sergio Vidal; Bernd W. Scheithauer; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

3.  CEBPD suppresses prolactin expression and prolactinoma cell proliferation.

Authors:  Yunguang Tong; Jin Zhou; Jun Mizutani; Hidenori Fukuoka; Song-Guang Ren; Arthur Gutierrez-Hartmann; H Phillip Koeffler; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2011-10-06

4.  Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl-2 family of proteins.

Authors:  E Kulig; L Jin; X Qian; E Horvath; K Kovacs; L Stefaneanu; B W Scheithauer; R V Lloyd
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

Review 5.  Pituitary hyperplasia.

Authors:  E Horvath; K Kovacs; B W Scheithauer
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

6.  Use of a prolactin-Cre/ROSA-YFP transgenic mouse provides no evidence for lactotroph transdifferentiation after weaning, or increase in lactotroph/somatotroph proportion in lactation.

Authors:  Emma Castrique; Marta Fernandez-Fuente; Paul Le Tissier; Andy Herman; Andy Levy
Journal:  J Endocrinol       Date:  2010-02-05       Impact factor: 4.286

7.  Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.

Authors:  Marcelo Paez-Pereda; Damiana Giacomini; Damian Refojo; Alberto Carbia Nagashima; Ursula Hopfner; Yvonne Grubler; Alberto Chervin; Victoria Goldberg; Rodolfo Goya; Shane T Hentges; Malcolm J Low; Florian Holsboer; Gunter K Stalla; Eduardo Arzt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

8.  Pituitary Sex Steroid Receptors: Localization and Function.

Authors:  Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

9.  The Pituitary in Gigantism.

Authors:  Bernd W. Scheithauer; Kalman T. Kovacs; Lucia Stefaneanu; Eva Horvath; Laurie A. Kane; William F. Young; Ricardo V. Lloyd; Raymond V. Randall; Dudley H. Davis
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

10.  Octreotide Effect on Growth Hormone and Somatostatin Subtype 2 Receptor mRNAs of the Human Pituitary Somatotroph Adenomas.

Authors:  Lucia Stefaneanu; Kalman Kovacs; Kamal Thapar; Eva Horvath; Shlomo Melmed; Yona Greenman
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.